Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer

Gut

Volumn 57, Issue 3, 2008, Pages 298-305

  Derakhshan, M H ^a,b   Malekzadeh, R ^b   Watabe, H ^a   Yazdanbod, A ^c   Fyfe, V ^a   Kazemi, A ^b   Rakhshani, N ^d   Didevar, R ^c   Sotoudeh, M ^b   Zolfeghari, A A ^c   McColl, K E L ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF TEHRAN   (Iran)

^c ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ATROPHIC GASTRITIS; CANCER CLASSIFICATION; CARDIA; CARDIA CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOCHEMISTRY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; STOMACH ADENOCARCINOMA; SYMPTOM; UPPER GASTROINTESTINAL TRACT;

ADENOCARCINOMA; AGED; CARDIA; CASE-CONTROL STUDIES; FEMALE; GASTRITIS, ATROPHIC; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PEPSINOGEN C; RISK FACTORS; SMOKING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 39649117136     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.137364     Document Type: Article

References (51)

1. Correa P, Haenszel W, Cuello C, et al. A model for gastric cancer epidemiology. Lancet 1975;2:58-60.
2. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
3. Asaka M, Kimura T, Kato M, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
4. Hansson LR, Engstrand L, Nyren O, et al. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885-8.
5. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
6. Kitahara F, Kobayashi K, Sato T, et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693-7.
7. Nishino Y, Inoue M, Tsuji I, et al. Tobacco smoking and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2006;36:800-7.
8. Sjodahl K, Lu Y, Nilsen TI, et al. Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer 2007;120:128-32.
9. Gonzalez CA, Pera G, Agudo A, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2003;107:629-34.
10. Rios-Castellanos E, Sitas F, Shepherd NA, et al. Changing pattern of gastric cancer in Oxfordshire. Gut 1992;33:1312-7.
11. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
12. Anandasabapathy S, Jhamb J, Davila M, et al. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007;109:668-74.
13. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003;98:940-8.
14. Souza RF, Shewmake K, Terada LS, et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's oesophagus. Gastroenterology 2002;122:299-307.
15. Theisen J, Peters JH, Fein M, et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg 2005;241:63-8.
16. Lassen A, Hallas J, de Muckadell OB. Esophagitis: incidence and risk of esophageal adenocarcinoma - a population-based cohort study. Am J Gastroenterol 2006;101:1193-9.
17. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005;191:761-7.
18. Inomata Y, Koike T, Ohara S, et al. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status. Am J Gastroenterol 2006;101:926-33.
19. Devesa SS, Fraumeni JF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999;91:747-9.
20. Derakhshan MH, Yazdanbod A, Sadjadi AR, et al. High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 2004;53:1262-6.
21. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and non cardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52.
22. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.
23. Limburg P, Qiao Y, Mark S, et al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-33.
24. Kamangar F, Qiao YL, Blaser MJ. et al. Helicobacter pylori and esophageal and gastric cancers in a prospective study in China. Br J Cancer 2007;96:172-6.
25. Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999;94:2373-9.
26. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
27. Ekstrom AM, Held M, Hansson LE, et al. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91.
28. Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology 2001;121:1286-93.
29. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456-63.
30. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and H. pylori status. Gut 2007;56:918-25.
31. Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer 2003;107:113-8.
32. Annual report on cancer incidence, Ardabil Cancer Registry, Ardabil University of Medical Sciences, 2004.
33. Percy C, Van Holten V, Mair C (eds). International Classification of Disease, 2nd edition. Geneva: World Health Organization, 1990.
34. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
35. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M, et al. Lower esophagus in dyspeptic Iranian patients: a prospective study. J Gastroenterol Hepatol 2003;18:315-21.
36. SPSS for Windows, Version 14.0, SPSS Inc, Chicago, IL, USA.
37. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
38. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005;54:764-8.
39. Uemura N, Okamoto S, Yamamoto S. H. pylori infection and the development of gastric cancer. Keio J Med 2002;51(Suppl 2):63-8.
40. Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998;93:1271-6.
41. Handa Y, Saitoh T, Kawaguchi M, et al. Association of Helicobacter pylori and diffuse type gastric cancer. J Gastroenterol 1996;31(Suppl 9):29-32.
42. Dunbier A, Guilford P. Hereditary diffuse gastric cancer. Adv Cancer Res 2001;83:55-65.
43. Sotoudeh M, Derakhshan MH, Abedi-Ardakani B. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci 2008;53:27-33. [May 10; Epub ahead of print]
44. Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005;16:285-94.
45. Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004;7:46-53.
46. Solaymani-Dodaran M, Logan RF, West J, et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53:1070-4.
47. Veugelers PJ, Porter GA, Guernsey DL, et al. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006;19:321-8.
48. Kimura K. Chronological changes of atrophic gastritis. Nippon Shokakibyo Gakkai Zasshi 1973;70:307-15.
49. Kimura K, Satoh K, Ido K, et al. Gastritis in the Japanese stomach. Scand J Gastroenterol Supp 1996;214:17-20; discussion 21-3.
50. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
51. Knight T, Wyatt J, Wilson A, et al. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73:819-24.